Even among the minority of patients who are diagnosed with early stage disease and undergo resection, most survive less than 5 years (short-term survivors (STS), however a unique subset of patients survive >5 years post-surgery coined long-term survivors (LTS) (Clin Cancer Res 2015;21:1944-1950). Recent human and mice studies suggests that the gut microbiome may play a role in pancreatic cancer initiation and progression through immune system modulation. Read more . . .